- Home
- MRAM vs AVTX Comparison
MRAM vs AVTX Comparison
Compare MRAM & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRAM | AVTX |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.8M | 328.4M |
| IPO Year | 2016 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MRAM | AVTX |
|---|---|---|
| Price | $28.89 | $16.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $18.50 | ★ $40.57 |
| AVG Volume (30 Days) | ★ 5.0M | 2.1M |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,417,000.00 | $27,813,137.00 |
| Revenue This Year | $10.22 | N/A |
| Revenue Next Year | $7.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 37.51 | ★ 2312.27 |
| 52 Week Low | $5.49 | $3.43 |
| 52 Week High | $51.50 | $24.27 |
Technical Indicators
Market Signals| Indicator | MRAM | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.28 | 47.84 |
| Support Level | $8.23 | $13.70 |
| Resistance Level | $51.50 | $19.39 |
| Average True Range (ATR) | 5.51 | 1.95 |
| MACD | 0.04 | -0.29 |
| Stochastic Oscillator | 33.54 | 29.77 |
Price Performance
Historical ComparisonAbout MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.